Capd peritonitis mortalty

29
CAPD peritonitis

Transcript of Capd peritonitis mortalty

Page 1: Capd peritonitis mortalty

CAPD peritonitis

Page 2: Capd peritonitis mortalty

Content

• Introduction• ISPD guideline • Hospital Pulau Pinang clinical audit on CAPD

peritonitis

Page 3: Capd peritonitis mortalty

PERITONEAL DIALYSIS

ContinuousAmbulatoryPeritonealDialysis

Page 4: Capd peritonitis mortalty

AutomatedPeritonealDialysis

PERITONEAL DIALYSIS

Page 5: Capd peritonitis mortalty

CAPD peritonitis

• Peritonitis is a common clinical problem that occurs in patients treated by peritoneal dialysis

• The incidence of peritonitis varies from center to center

• During the past decade approximately 1 episode every 24 patient-treatment-months was observed

• because of exceptional patient education, as well as new connector and catheter technologies

Page 6: Capd peritonitis mortalty

• A variety of different regimens have been proposed based upon these experiences

• Antibiotics have been administered intraperitoneally (IP), or intravenously (IV), or orally, and a number of different dosing regimens have been utilized

• Unfortunately, no single regimen has been shown in appropriate clinical trials to be most efficacious.

Page 7: Capd peritonitis mortalty

ISPD Guidelines/Recommendations ADULT PERITONEAL DIALYSIS-RELATED

PERITONITIS TREATMENTRECOMMENDATIONS: 2005 Update

William F. Keane,1 George R. Bailie,2 Elizabeth Boeschoten,3 Ram Gokal,4 Thomas A. Golper,5 Clifford J. Holmes,6 Yoshindo Kawaguchi,7 Beth

Piraino,8 Miguel Riella,9 Stephen Vas10

Page 8: Capd peritonitis mortalty

DEFINITION OF CAPD PERITONITIS

2 out of 3 of the following criteria 1. Abdominal pain2. Cloudy effluent with

a cell count > 100 cells/ mm3 ; 50% of which is PMN

3. Culture positive

Page 9: Capd peritonitis mortalty

Initial Clinical Evaluation of Patient with Suspected Peritoneal Dialysis-Related Peritonitis

• Symptoms: cloudy fluid and abdominal pain • Do cell count and differential • Gram stain and culture on initial drainage • Initiate empiric therapy • Choice of final therapy should always be

guided by antibiotic sensitivities

Page 10: Capd peritonitis mortalty

• on many occasions the Gram stain is unavailable, delayed, or negative for any specific organisms Empiric therapy is indicated in these conditions

• There is a slight statistical likelihood that the causative pathogen will be the same as the most recent infection

• If the exit site is infected with pseudomonas or S. aureus when peritonitis presents, there is a high probability that the peritonitis is caused by the same organism

• If the patient is having frequent peritonitis episodes, then relapse or recurrence with the same organism is likely.

Page 11: Capd peritonitis mortalty

Empiric Initial Therapy, for Peritoneal Dialysis-Related Peritonitis, Stratified for Residual Urine

VolumeAntibiotic Residual urine output

< 100 mL/dayResidual urine output> 100 mL/day

Cefazolin or cephalothin 1 g/bag, q.d. 20 mg/kg BW/bag, q.d.

or

15 mg/kg BW/bag, q.d.

Ceftazidime 1 g/bag, q.d. 20 mg/kg BW/bag, q.d.Gentamicin, tobramycin, netilmycin

0.6 mg/kg BW/bag, q.d. Not recommended

Amikacin 2 mg/kg BW/bag, q.d. Not recommended

Page 12: Capd peritonitis mortalty

?vancomycin• Internationally, the prevalence of vancomycin-resistant

organisms has dramatically increased and this increase has been particularly evident in larger university hospitals where up to 14% of enterococci may be resistant

• Vancomycin resistance has been associated with resistance to other penicillins and aminoglycosides, thus presenting a treatment dilemma

• This change in vancomycin sensitivity has prompted a number of worldwide agencies to discourage routine use of vancomycin for prophylaxis, for empiric therapy, or for oral use for Clostridium difficile enterocolitis.

Page 13: Capd peritonitis mortalty

• The major concern is that the vancomycin-resistance gene is transmitted to staphylococcal strains, creating an issue of major epidemiological importance

• It is recommended for use in methicillin-resistant S. aureus (MRSA) infections and in treatment of infections due to beta-lactam-resistant organisms, as well as in treatment for infections in patients that have serious gram-positive infections and that are allergic to other agents.

Page 14: Capd peritonitis mortalty

Treatment strategies after identifying gram positive organism

TABLE 4

Treatment Strategies After Identification of Gram-Positive

Organism on Culture

Enterococcus Staphylococcus aureus Other gram-positive organism

(Coagulase-negative staphylococcus)

At 24 to 48 hours

Stop cephalosporinsStop ceftazidime or aminoglycoside Stop ceftazidime or aminoglycoside

Start ampicillin 125 mg/L/bag Continue cephalosporin Continue cephalosporin

Consider adding aminoglycoside

Add rifampin 600 mg/day, oral

If ampicillin-resistant, start If MRSA, start vancomycin If MRSE and clinically not

vancomycin or clindamycin or clindamycin responding, start vancomycin

If VRE, consider quinupristin/dalfopristin

or clindamycin

Duration of therapy

14 days 21 days 14 days

Page 15: Capd peritonitis mortalty

Treatment Recommendations if a Gram-Negative Organism Is Identified on Culture at 24 to 48 hours

Duration of therapy

Single gram-negative organism

Adjust antibiotics to sensitivity 14 days

< 100 mL urine, aminoglycoside

> 100 mL urine, ceftazidime

Pseudomonas/stenotrophomonas

Continue ceftazidime and add 21 days

< 100 mL urine, aminoglycoside (see Empiric Therapy, Table 2)

> 100 mL urine, ciprofloxacin 500 mg, p.o. b.i.d.

or piperacillin 4 g IV q.12 hours

or sulfamethoxazole/trimethoprim 1_2 DS/day

or aztreonam load 1 g/L; maintenance dose 250 mg/L IP/bag

Multiple gram-negatives and/or anaerobes

Continue cefazolin and ceftazidime and add

21 days

metronidazole, 500 mg q.8 hours, p.o., IV, or rectally

If no change in clinical status, consider surgical intervention

Page 16: Capd peritonitis mortalty

Treatment Strategies if Peritoneal Dialysis Fluid Cultures Are Negative at 24 to 48 Hours or Not

Performed Continue initial therapy Duration of therapy

If clinical improvementDiscontinue ceftazidime or aminoglycoside

Continue cephalosporin 14 days

If no clinical improvement at 96 hours

If culture positive, adjust therapy accordingly

Repeat cell count, Gram stain, and culture

14 days

If culture negative, continue antibiotics, consider infrequent pathogens and/or catheter removal

14 days

Page 17: Capd peritonitis mortalty

Catheter removal

• Should be considered when peritonitis is unlikely to resolve with catheter in situ – Fungal peritonitis– TB peritonitis – Perforated bowel – Persistent exit / tunnel infection – Not responsive to second line antibiotic – Relapsing peritonitis not responding to treatment

Page 18: Capd peritonitis mortalty

AUDIT:PERITONITIS RATE IN THE CAPD UNIT

CAPD UNIT HOSPITAL PULAU PINANG

Page 19: Capd peritonitis mortalty

OBJECTIVES

To determine o the incidence of peritonitiso outcome of peritonitiso types of organsims causing peritonitis

Page 20: Capd peritonitis mortalty

RESULTS

Page 21: Capd peritonitis mortalty

CHARACTERISTICS of all PD patientsTotal Number of patients 196Age Mean : 47 years, SD:20.6

Range : 6 – 87 years

Duration on PD Mean : 37.9 months ,SD :34.7Range : 0.5 – 172 months

Male : Female ratio 95 : 101(48%) (52%)

Primary disease causing ESRDDiabetes mellitusHPTGNUnknownOthers

80 (41%)21 (11%)22 (11%)22 (11%)51 (26%)

Page 22: Capd peritonitis mortalty

PD Peritonitis

• 28 episodes of peritonitis in 23 patients• Mean age = 52 years (range : 15- 81 yrs)• Male: Female ratio = 7 patients:16 patients

(1:2.2)• Self care in 9 patients (39 %) Assisted PD in 14 patients (61%)

Page 23: Capd peritonitis mortalty

PERITONITIS RATE

• 28 episodes of peritonitis (EOP) in 23 patients in 1006.6 patient-months

i.e. 1 in 36 patient-months KPI peritonitis rate is 1 in 24 patient-months Optimal standard for peritonitis rate is 1 in 42

patient-months

Page 24: Capd peritonitis mortalty

PERITONITIS CULTURE YIELD

Culture positive yield rate is below recommended international rate of at least 80%

Page 25: Capd peritonitis mortalty

PERITONITIS CULTURE YIELD

Page 26: Capd peritonitis mortalty

CAUSATIVE ORGANISMSNumber

Gram Negative(67%) E.Coli Pseudomonas aeruginosa Acinetobacter sp Haemophilus Influenza Sphingomonas paucibilis Serratia Marcesceus

3 2 2 1 1 1

Gram Positive (20%) Coagulase Negative Staph Staphylococcus aureus

2 1

Fungus (13%) Candida sp 2

TOTAL 15

Page 27: Capd peritonitis mortalty

OUTCOME OF PERITONITIS

28 episodes

17 resolved 7 T/C removal 4 died (60.7%) (25%) (14.2%)

Tenckhoff Removal

1 reinsertion 4 changed modality 2 still awaiting (continued CAPD) reinsertion

Page 28: Capd peritonitis mortalty

CONCLUSION Peritonitis rate is 1 in 36 patient-months

--below the optimal standard (1 in 42 patient-months) 60.7% of patients with CAPD peritonitis resolved with

treatment 25% required T/C removal 14.2% died (4) - 1 pt had advanced Ca cervix

- 3 pt had concomitant nosocomial sepsis

Majority of the organism isolated is Gram negative organism

Page 29: Capd peritonitis mortalty

Thank you for your attention !